Draftkings Inc. diskutieren
Sell Draftkings Inc.
Buy DraftKings Inc.
DraftKings Inc. (NASDAQ: DKNG) was upgraded by analysts at Argus from a "hold" rating to a "buy" rating.
Ratings data for DKNG provided by MarketBeat
DraftKings Inc. (NASDAQ: DKNG) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $23.00 price target on the stock.
Ratings data for DKNG provided by MarketBeat
DraftKings Inc. (NASDAQ: DKNG) had its price target raised by analysts at Susquehanna from $26.00 to $28.00. They now have a "positive" rating on the stock.
Ratings data for DKNG provided by MarketBeat
DraftKings Inc. (NASDAQ: DKNG) had its price target raised by analysts at Benchmark Co. from $23.00 to $26.00. They now have a "buy" rating on the stock.
Ratings data for DKNG provided by MarketBeat
DraftKings Inc. (NASDAQ: DKNG) had its price target raised by analysts at Oppenheimer Holdings Inc. from $28.00 to $30.00. They now have an "outperform" rating on the stock.
Ratings data for DKNG provided by MarketBeat
DraftKings Inc. (NASDAQ: DKNG) had its price target raised by analysts at Roth Mkm from $15.00 to $18.00. They now have a "sell" rating on the stock.
Ratings data for DKNG provided by MarketBeat
DraftKings Inc. (NASDAQ: DKNG) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $30.00 price target on the stock, up previously from $19.00.
Ratings data for DKNG provided by MarketBeat
DraftKings Inc. (NASDAQ: DKNG) was upgraded by analysts at Bank of America Co. from a "neutral" rating to a "buy" rating. They now have a $35.00 price target on the stock, up previously from $25.00.
Ratings data for DKNG provided by MarketBeat
DraftKings Inc. (NASDAQ: DKNG) had its price target raised by analysts at Benchmark Co. from $26.00 to $32.00. They now have a "buy" rating on the stock.
Ratings data for DKNG provided by MarketBeat
DraftKings Inc. (NASDAQ: DKNG) had its price target raised by analysts at Morgan Stanley from $31.00 to $32.00. They now have an "overweight" rating on the stock.
Ratings data for DKNG provided by MarketBeat
DraftKings Inc. (NASDAQ: DKNG) had its price target raised by analysts at Roth Mkm from $18.00 to $20.00. They now have a "sell" rating on the stock.
Ratings data for DKNG provided by MarketBeat
DraftKings Inc. (NASDAQ: DKNG) had its price target raised by analysts at TD Cowen from $30.00 to $35.00. They now have an "outperform" rating on the stock.
Ratings data for DKNG provided by MarketBeat
DraftKings Inc. (NASDAQ: DKNG) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $36.00 price target on the stock.
Ratings data for DKNG provided by MarketBeat
DraftKings Inc. (NASDAQ: DKNG) had its price target raised by analysts at Oppenheimer Holdings Inc. from $36.00 to $40.00. They now have an "outperform" rating on the stock.
Ratings data for DKNG provided by MarketBeat
DraftKings Inc. (NASDAQ: DKNG) had its price target raised by analysts at TD Cowen from $35.00 to $37.00. They now have an "outperform" rating on the stock.
Ratings data for DKNG provided by MarketBeat
DraftKings Inc. (NASDAQ: DKNG) had its price target raised by analysts at Roth Mkm from $20.00 to $23.00. They now have a "sell" rating on the stock.
Ratings data for DKNG provided by MarketBeat
DraftKings Inc. (NASDAQ: DKNG) had its price target raised by analysts at Morgan Stanley from $32.00 to $35.00. They now have an "overweight" rating on the stock.
Ratings data for DKNG provided by MarketBeat
DraftKings Inc. (NASDAQ: DKNG) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $44.00 price target on the stock.
Ratings data for DKNG provided by MarketBeat
Neueste Beiträge
StockNews_com in Ampio Pharmaceuticals Inc. diskutieren